Cargando…

PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations

Immune checkpoint inhibitors (ICI) targeting programmed cell death-1 or its ligand (PD-L1) have improved outcomes in non-small cell lung cancer (NSCLC). High tumor PD-L1 expression, detected by immunohistochemistry (IHC) typically on formalin-fixed paraffin-embedded (FFPE) histological specimens, is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansour, Mohammed S. I., Malmros, Karina, Mager, Ulrich, Ericson Lindquist, Kajsa, Hejny, Kim, Holmgren, Benjamin, Seidal, Tomas, Dejmek, Annika, Dobra, Katalin, Planck, Maria, Brunnström, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101150/ https://www.ncbi.nlm.nih.gov/pubmed/35562908 http://dx.doi.org/10.3390/ijms23094517

Ejemplares similares

Higher concordance of PD‐L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma
por: Mansour, Mohammed S. I., et al.
Publicado: (2021)

Factors Influencing Concordance of PD-L1 Expression between Biopsies and Cytological Specimens in Non-Small Cell Lung Cancer
por: Mansour, Mohammed S. I., et al.
Publicado: (2021)

Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics
por: Ericson Lindquist, Kajsa, et al.
Publicado: (2021)

Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines
por: Ericson Lindquist, Kajsa, et al.
Publicado: (2022)

Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer
por: Karlsson, Anna, et al.
Publicado: (2015)

Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series
por: Ericson-Lindquist, Kajsa, et al.
Publicado: (2017)

Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
por: Lindquist, Kajsa Ericson, et al.
Publicado: (2017)

A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer
por: Karlsson, Anna, et al.
Publicado: (2019)

Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center
por: Isaksson, Sofi, et al.
Publicado: (2020)

The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer
por: Winslow, Sofia, et al.
Publicado: (2016)

Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer
por: Wangefjord, Sakarias, et al.
Publicado: (2013)

Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens
por: Aytac, Berna, et al.
Publicado: (2011)

Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2015)

The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I–II
por: SKIRNISDOTTIR, INGIRIDUR, et al.
Publicado: (2016)

Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
por: Hjerpe, Anders, et al.
Publicado: (2015)

The Role of Syndecan-1 in Cellular Signaling and its Effects on Heparan Sulfate Biosynthesis in Mesenchymal Tumors
por: Szatmári, Tünde, et al.
Publicado: (2013)

Enterobius vermicularis in appendectomy specimens; Clinicopathological assessment: Cross sectional study
por: Hasan, Abdulkarim, et al.
Publicado: (2020)

Clinicopathologic correlations of superficial esophageal adenocarcinoma in endoscopic submucosal dissection specimens
por: Dhingra, Sadhna, et al.
Publicado: (2021)

CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
por: Isaksson, Sofi, et al.
Publicado: (2017)

Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC—A retrospective single-center experience
por: Karadzovska-Kotevska, Marija, et al.
Publicado: (2022)

Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
por: Wangefjord, Sakarias, et al.
Publicado: (2013)

Napsin A as a marker of clear cell ovarian carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2013)

Immunoexpression of PD-L1 and PD-1 and Its Clinicopathological Correlation in Urothelial Carcinomas
por: Kumar, Utpal, et al.
Publicado: (2021)

Multiplex Soluble Biomarker Analysis from Pleural Effusion
por: Javadi, Joman, et al.
Publicado: (2020)

Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer
por: Arbajian, Elsa, et al.
Publicado: (2020)

Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after (177)Lu-DOTA-Tyr(3)-octreotate treatment: a histological study in xenografted mice
por: Erlandsson, Ann, et al.
Publicado: (2011)

Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors
por: Hashimoto, Kazuhiko, et al.
Publicado: (2023)

Clinicopathological analysis of PD-L2 expression in colorectal cancer
por: Guo, Peng-Da, et al.
Publicado: (2018)

Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
por: Micke, Patrick, et al.
Publicado: (2019)

Immunohistochemical Loss of the DNA Mismatch Repair Proteins MSH2 and MSH6 in Malignant Fibrous Histiocytomas
por: Ericson, Kajsa, et al.
Publicado: (2004)

Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma
por: Hjerpe, Anders, et al.
Publicado: (2020)

Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy
por: Zubac, Dragomir P, et al.
Publicado: (2010)

PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
por: Bai, Yanhua, et al.
Publicado: (2017)

Maintaining Specimen Integrity for G6PD Screening by Cytofluorometric Assays
por: Kahn, Maria, et al.
Publicado: (2015)

Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma
por: Miyake, Makito, et al.
Publicado: (2020)

Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
por: Wu, Hong, et al.
Publicado: (2021)

High-pressure crystallography of periodic and aperiodic crystals
por: Hejny, Clivia, et al.
Publicado: (2015)

Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication
por: Szatmári, Tünde, et al.
Publicado: (2015)

The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer
por: Bjersand, Kathrine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5oqu7p4bg88jnek7aeo6fc8goe